How long do you take Mounjaro for — and what happens when you stop?

You're somewhere in the middle of treatment and wondering how long this goes on

That question usually surfaces around week twelve, or when the scales slow down, or when a repeat feels like a big commitment. It's a reasonable thing to sit with. The honest answer is that there is no built-in end date. The UK Summary of Product Characteristics for tirzepatide does not cap treatment at a specific number of months. What it describes instead is a medicine taken alongside a reduced-calorie diet and increased physical activity, with progress reviewed regularly by the prescriber.

The SURMOUNT-1 trial (involving 2,539 adults with obesity over 72 weeks) is the reference point most cited when discussing how long treatment takes to produce meaningful results. Average body-weight reduction at the 15mg dose reached around 20–21% by the end of that period, with the curve still moving at the close. That does not mean everyone needs 72 weeks, or that 72 weeks is a ceiling. It means the evidence base was built on that timeframe, and results continued accumulating throughout it. You can read the NHS tirzepatide patient information for a plain-English overview of what to expect during treatment.

What drives the actual duration is clinical progress. If the treatment is working (meaningful weight loss, tolerability within an acceptable range, no new contraindications) a prescriber has good grounds to continue. If it has stopped working or side effects outweigh benefit, stopping becomes the conversation. Our page on how long you can take Mounjaro explores these factors in more detail, including what ongoing use looks like in practice.

The NICE 5% rule: when a prescriber will reconsider

NICE technology appraisal TA1026 sets a specific checkpoint. If someone has not lost at least 5% of their body weight after six months at the highest dose they can tolerate, the prescriber should review whether continuing makes clinical sense. This is not a punishment clause; it is a structured way of identifying people for whom tirzepatide is not producing sufficient benefit relative to its cost and commitment.

For the majority of people who do respond, that 5% threshold is cleared comfortably during the titration phase, well before the six-month mark. The checkpoint matters most for those whose response is modest. If you are not seeing much movement after three months, that is a signal worth raising with your prescriber early rather than waiting for the formal review.

Private prescribing follows the same clinical logic, even without the NHS commissioning framework. A responsible prescriber reviews progress at each repeat, not just to tick a box, but because continued prescribing without evidence of benefit is not good practice. At nume, no repeat is issued without a clinical re-review. That applies whether you are on your second pen or your twelfth.

What happens to weight when you stop, and does stopping have to be all at once?

The data on this is consistent and worth knowing before you reach that point. In SURMOUNT trials, participants who stopped tirzepatide regained a significant proportion of lost weight within a year of stopping, even when they maintained lifestyle changes. The medicine suppresses appetite through dual GIP and GLP-1 receptor activity; removing it removes much of that suppression. The biology is real. This does not mean treatment must be lifelong for everyone, but it does mean stopping should be a considered clinical conversation rather than a cost-led decision made quietly. If the cost of ongoing treatment is part of your thinking, that is a legitimate thing to discuss openly with your prescriber rather than just stopping.

There is no evidence that abrupt cessation causes harm directly, but a gradual step-down is sometimes considered where the prescriber judges it appropriate. The Patient Information Leaflet and your prescriber are the right sources for the specifics of stopping safely. If you are weighing up how long you need to take Mounjaro for weight loss, our dedicated page covers the maintenance question alongside typical treatment durations. For those thinking about long-term weight management more broadly, our treatment overview sets out where Mounjaro sits alongside other licensed options.

How to think about duration if you are just starting out

The titration schedule (starting at 2.5mg and stepping up roughly every four weeks) takes around four to five months to reach a maintenance dose for most people. Results accumulate across that period and beyond. Asking how long you will take Mounjaro for on day one is a bit like asking how long a course of physiotherapy will run at the first session: the right answer depends on how your body responds, what your goals are, and what your prescriber sees. Our page on how long Mounjaro takes to work gives realistic timeframes for early changes, and the question of when effects typically begin is answered there too.

The short version: plan for at least six months before drawing conclusions. Many people continue for a year or longer with ongoing clinical oversight. The prescriber decides at each review, not at the outset. If you want to understand whether you are likely to be clinically suitable before committing to anything, checking your eligibility through a free consultation is the right first step, there is no obligation to proceed.